Primecap Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,451,400
| Closed | -$5.67M | – | 307 |
|
|
2019
Q1 | $5.67M | Sell |
5,451,400
-54,900
| -1% | -$44.7K | ﹤0.01% | 252 |
|
|
2018
Q4 | $4.12M | Sell |
5,506,300
-192,400
| -3% | -$290K | ﹤0.01% | 253 |
|
|
2018
Q3 | $12.1M | Buy |
5,698,700
+135,000
| +2% | +$323K | 0.01% | 239 |
|
|
2018
Q2 | $12.9M | Sell |
5,563,700
-3,200
| -0.1% | -$9.32K | 0.01% | 230 |
|
|
2018
Q1 | $17.7M | Buy |
5,566,900
+1,300
| +0% | +$3.58K | 0.01% | 217 |
|
|
2017
Q4 | $22.8M | Sell |
5,565,600
-300
| -0% | -$1.3K | 0.02% | 204 |
|
|
2017
Q3 | $25.2M | Buy |
5,565,900
+12,300
| +0.2% | +$49.8K | 0.02% | 195 |
|
|
2017
Q2 | $18.5M | Buy |
5,553,600
+3,647,000
| +191% | +$15.1M | 0.02% | 212 |
|
|
2017
Q1 | $17.6M | Buy |
1,906,600
+105,900
| +6% | +$930K | 0.02% | 206 |
|
|
2016
Q4 | $13.9M | Buy |
1,800,700
+498,000
| +38% | +$4.58M | 0.01% | 213 |
|
|
2016
Q3 | $14.9M | Buy |
1,302,700
+1,086,900
| +504% | +$12.7M | 0.01% | 211 |
|
|
2016
Q2 | $2.66M | Hold |
215,800
| – | – | ﹤0.01% | 253 |
|
|
2016
Q1 | $2.18M | Buy |
215,800
+24,000
| +13% | +$282K | ﹤0.01% | 256 |
|
|
2015
Q4 | $4.32M | Buy |
191,800
+1,000
| +0.5% | +$20.5K | ﹤0.01% | 243 |
|
|
2015
Q3 | $3.17M | Hold |
190,800
| – | – | ﹤0.01% | 251 |
|
|
2015
Q2 | $4.29M | Sell |
190,800
-15,493
| -8% | -$382K | ﹤0.01% | 238 |
|
|
2015
Q1 | $5.32M | Sell |
206,293
-12,107
| -6% | -$307K | 0.01% | 235 |
|
|
2014
Q4 | $4.75M | Hold |
218,400
| – | – | ﹤0.01% | 236 |
|
|
2014
Q3 | $4.13M | Sell |
218,400
-48,000
| -18% | -$965K | ﹤0.01% | 236 |
|
|
2014
Q2 | $6.21M | Sell |
266,400
-74,300
| -22% | -$1.83M | 0.01% | 226 |
|
|
2014
Q1 | $11.5M | Hold |
340,700
| – | – | 0.01% | 209 |
|
|
2013
Q4 | $10.1M | Buy |
340,700
+96,000
| +39% | +$1.76M | 0.01% | 214 |
|
|
2013
Q3 | $3.75M | Buy |
+244,700
| New | +$4.53M | ﹤0.01% | 230 |
|
Primecap Management's OMED Position: Q2 2019 in Review
Primecap Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 5,451,400 shares — an estimated $5.67M sold.
Primecap Management first reported a position in OMED in Q3 2013 and held it in 23 quarters. The position peaked at $25.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Primecap Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Primecap Management sold 5,451,400 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $5.67M.
- Primecap Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 23 quarters.
- Primecap Management's OncoMed Pharmaceuticals, Inc. position peaked at $25.2M in Q3 2017.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Primecap Management's 13F filing for Q2 2019, filed 14 Aug 2019.